enVVeno Medical (NVNO) Enterprise Value (2017 - 2026)

enVVeno Medical's Enterprise Value history runs 10 years deep, the most recent figure standing at -$24.9 million for Q1 2026.

• In Q1 2026, Enterprise Value rose 35.98% year-over-year to -$24.9 million; the TTM figure through Mar 2026 stood at -$24.9 million (up 35.98% YoY), while the FY2025 annual figure was -$28.2 million, up 34.62% from the prior year.
• Enterprise Value was -$24.9 million for Q1 2026 at enVVeno Medical, up from -$28.2 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$24.9 million in Q1 2026 to a low of -$66.1 million in Q1 2023.
• Historically, Enterprise Value has averaged -$39.3 million across 5 years, with a median of -$39.0 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Enterprise Value soared 36.28% in 2023, then slumped 88.27% in 2024.
• A 5-year view of Enterprise Value shows it stood at -$39.0 million in 2022, then fell by 18.87% to -$46.4 million in 2023, then grew by 7.02% to -$43.2 million in 2024, then jumped by 34.62% to -$28.2 million in 2025, then increased by 11.63% to -$24.9 million in 2026.
• The last three Enterprise Value figures came in at -$24.9 million (Q1 2026), -$28.2 million (Q4 2025), and -$31.0 million (Q3 2025), per Business Quant data.